Vaccination with PANHPVAX 40µg clinical trials

PANHPVAX, Study of a New HPV Vaccine in Healthy Volunteers

This study is testing a new HPV vaccine called PANHPVAX in healthy adults aged 18-45. It aims to check if different doses are safe and well-tolerated. This new vaccine works differently to existing ones, potentially protecting against more types of HPV.